US FDA staff flags concerns on Merck’s chronic cough drug, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

The concerns were raised after the company had submitted additional efficacy data to the U.S. Food and Drug Administration (FDA), which had declined to approve the drug in January last year., The concerns were raised after the company had submitted additional efficacy data to the U.S. Food and Drug Administration (FDA), which had declined to approve the drug in January last year., , Read More

Leave a Reply

Your email address will not be published.